Mc Gettigan N, Boland K, O'Toole A. Letter to the Editor in Response to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease". Inflamm Bowel Dis 2022;28:e59-e60.
PMID: 35512142